Simplex Trading
PGNX

Simplex Trading’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Simplex Trading’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-205
Closed -$77K – 8773
2020
Q1 		$77K Sell
205
-205
-50% -$883 ﹤0.01% 4661
2019
Q4 		$208K Buy
410
+36
+10% +$190 ﹤0.01% 3711
2019
Q3 		$189K Buy
374
+27
+8% +$135 ﹤0.01% 3618
2019
Q2 		$214K Buy
+347
New +$1.67K ﹤0.01% 3402
2019
Q1 		– Sell
-222
Closed -$93K – 8239
2018
Q4 		$93K Sell
222
-21
-9% -$107 ﹤0.01% 3920
2018
Q3 		$152K Sell
243
-499
-67% -$3.83K ﹤0.01% 3959
2018
Q2 		$596K Buy
742
+441
+147% +$3.37K ﹤0.01% 2278
2018
Q1 		$32K Buy
301
+168
+126% +$1.12K ﹤0.01% 2890
2017
Q4 		$3K Sell
133
-8
-6% -$49 ﹤0.01% 5049
2017
Q3 		$7K Buy
141
+32
+29% +$203 ﹤0.01% 4162
2017
Q2 		$3K Buy
+109
New +$805 ﹤0.01% 5105
2017
Q1 		– Sell
-75
Closed -$30K – 7098
2016
Q4 		$30K Buy
75
+26
+53% +$192 ﹤0.01% 2665
2016
Q3 		$1K Buy
49
+17
+53% +$103 ﹤0.01% 5549
2016
Q2 		$1K Buy
+32
New +$155 ﹤0.01% 5565
2015
Q3 		– Sell
-155
Closed -$8K – 6498
2015
Q2 		$8K Buy
+155
New +$938 ﹤0.01% 3305

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $49.2B AUM 29.3% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Simplex Trading's PGNX Position: Q2 2020 in Review

Simplex Trading sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 200 shares.

Simplex Trading first reported a position in PGNX in Q1 2015 and held it in 16 quarters. The position peaked at $182K in Q3 2017. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Simplex Trading reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Simplex Trading sold 200 Progenics Pharmaceuticals Inc shares in Q2 2020.
  • Simplex Trading first reported a position in Progenics Pharmaceuticals Inc in Q1 2015 and held it in 16 quarters.
  • Simplex Trading's Progenics Pharmaceuticals Inc position peaked at $182K in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Simplex Trading's 13F filing for Q2 2020, filed 13 Jul 2020.